Inhibiteurs de l'intégrase du VIH (usage thérapeutique) < Inhibiteurs de la cystéine protéinase () < Inhibiteurs de la cystéine protéinase (isolement et purification)

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f KwdFr.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references indexed by Inhibiteurs de la cystéine protéinase ()

Number of relevant bibliographic references: 15.

Ident.	Authors (with country if any)	Title
000B45 (2019)	Kouji Ohnishi [Japon] ; Yasunao Hattori [Japon] ; Kazuya Kobayashi [Japon] ; Kenichi Akaji [Japon]	Evaluation of a non-prime site substituent and warheads combined with a decahydroisoquinolin scaffold as a SARS 3CL protease inhibitor.
001071 (2016)	Ji-Young Park [Corée du Sud] ; Jin-A Ko [Corée du Sud] ; Dae Wook Kim ; Young Min Kim [Corée du Sud] ; Hyung-Jun Kwon [Corée du Sud] ; Hyung Jae Jeong [Corée du Sud] ; Cha Young Kim [Corée du Sud] ; Ki Hun Park ; Woo Song Lee [Corée du Sud] ; Young Bae Ryu [Corée du Sud]	Chalcones isolated from Angelica keiskei inhibit cysteine proteases of SARS-CoV.
001269 (2015)	Michael Berry [Afrique du Sud] ; Burtram C. Fielding [Afrique du Sud] ; Junaid Gamieldien [Afrique du Sud]	Potential Broad Spectrum Inhibitors of the Coronavirus 3CLpro: A Virtual Screening and Structure-Based Drug Design Study.
001543 (2014)	Yahira M. Báez-Santos ; Sarah E. St. John ; Andrew D. Mesecar	The SARS-coronavirus papain-like protease: Structure, function and inhibition by designed antiviral compounds
001960 (2013)	Ji-Young Park [Corée du Sud] ; Jang Hoon Kim ; Jung Min Kwon ; Hyung-Jun Kwon ; Hyung Jae Jeong ; Young Min Kim ; Doman Kim ; Woo Song Lee ; Young Bae Ryu	Dieckol, a SARS-CoV 3CL(pro) inhibitor, isolated from the edible brown algae Ecklonia cava.
001964 (2013)	Pillaiyar Thanigaimalai [Japon] ; Sho Konno [Japon] ; Takehito Yamamoto [Japon] ; Yuji Koiwai [Japon] ; Akihiro Taguchi [Japon] ; Kentaro Takayama [Japon] ; Fumika Yakushiji [Japon] ; Kenichi Akaji [Japon] ; Yoshiaki Kiso [Japon] ; Yuko Kawasaki [États-Unis] ; Shen-En Chen [États-Unis] ; Aurash Naser-Tavakolian [États-Unis] ; Arne Schön [États-Unis] ; Ernesto Freire [États-Unis] ; Yoshio Hayashi [Japon]	Design, synthesis, and biological evaluation of novel dipeptide-type SARS-CoV 3CL protease inhibitors: Structure–activity relationship study
001C44 (2012)	Ji-Young Park [Corée du Sud] ; Jang Hoon Kim ; Young Min Kim ; Hyung Jae Jeong ; Dae Wook Kim ; Ki Hun Park ; Hyung-Jun Kwon ; Su-Jin Park ; Woo Song Lee ; Young Bae Ryu	Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases.
002566 (2010)	Falgun Shah [États-Unis] ; Prasenjit Mukherjee ; Prashant Desai ; Mitchell Avery	Computational approaches for the discovery of cysteine protease inhibitors against malaria and SARS.
002A10 (2009)	Cheng-Chung Lee [Taïwan] ; Chih-Jung Kuo ; Tzu-Ping Ko ; Min-Feng Hsu ; Yao-Chen Tsui ; Shih-Cheng Chang ; Syaulan Yang ; Shu-Jen Chen ; Hua-Chien Chen ; Ming-Chu Hsu ; Shin-Ru Shih ; Po-Huang Liang ; Andrew H-J Wang	Structural basis of inhibition specificities of 3C and 3C-like proteases by zinc-coordinating and peptidomimetic compounds.
002B97 (2009)	Krongsakda Phakthanakanok [Thaïlande] ; Khanok Ratanakhanokchai ; Khin Lay Kyu ; Pornthep Sompornpisut ; Aaron Watts ; Surapong Pinitglang	A computational analysis of SARS cysteine proteinase-octapeptide substrate interaction: implication for structure and active site binding mechanism.
003072 (2008)	Chunying Niu [Canada] ; Jiang Yin ; Jianmin Zhang ; John C. Vederas ; Michael N G. James	Molecular docking identifies the binding of 3-chloropyridine moieties specifically to the S1 pocket of SARS-CoV Mpro.
003584 (2007)	D H Goetz [États-Unis] ; Y. Choe ; E. Hansell ; Y T Chen ; M. Mcdowell ; C B Jonsson ; W R Roush ; J. Mckerrow ; C S Craik	Substrate specificity profiling and identification of a new class of inhibitor for the major protease of the SARS coronavirus.
004923 (2005)	Qishi Du [République populaire de Chine] ; Shuqing Wang ; Zhiqin Jiang ; Weina Gao ; Yun Li ; Dongqing Wei ; Kuo-Chen Chou	Application of bioinformatics in search for cleavable peptides of SARS-CoV M(pro) and chemical modification of octapeptides.
005525 (2004)	Jeffrey H. Toney [États-Unis] ; Sonia Navas-Martín [États-Unis] ; Susan R. Weiss [États-Unis] ; Andreas Koeller [États-Unis]	Sabadinine:  A Potential Non-Peptide Anti-Severe Acute-Respiratory-Syndrome Agent Identified Using Structure-Aided Design
006039 (2003)	Kanchan Anand [Allemagne] ; John Ziebuhr ; Parvesh Wadhwani ; Jeroen R. Mesters ; Rolf Hilgenfeld	Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdFr.i -k "Inhibiteurs de la cystéine protéinase ()" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdFr.i  \
                -Sk "Inhibiteurs de la cystéine protéinase ()" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdFr.i
   |clé=    Inhibiteurs de la cystéine protéinase ()
}}

---

This area was generated with Dilib version V0.6.33. Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021